Study shows Wegovy easing heart failure symptoms for patients with diabetes—helpful to Novo Nordisk as it makes case insurers should pay for the weight-loss medication
Study shows Wegovy easing heart failure symptoms for patients with diabetes—helpful to Novo Nordisk as it makes case insurers should pay for the weight-loss medication
The blockbuster drug from Novo Nordisk has a list price of about $1,350 per month in the US.